91 results match your criteria: "Inserm U1245 and Rouen University Hospital[Affiliation]"

Article Synopsis
  • * Recent studies have expanded the list of these gene variants, leading to updates on surveillance and intervention strategies for at-risk children, including early hematopoietic stem cell transplantation.
  • * A 2023 expert panel provided new recommendations for monitoring these children, emphasizing personalized approaches based on genetic profiles, including regular check-ups and specialized testing like bone marrow examinations and gene sequencing.
View Article and Find Full Text PDF

Purpose: Interneuronopathies are a group of neurodevelopmental disorders characterized by deficient migration and differentiation of gamma-aminobutyric acidergic interneurons resulting in a broad clinical spectrum, including autism spectrum disorders, early-onset epileptic encephalopathy, intellectual disability, and schizophrenic disorders. SP9 is a transcription factor belonging to the Krüppel-like factor and specificity protein family, the members of which harbor highly conserved DNA-binding domains. SP9 plays a central role in interneuron development and tangential migration, but it has not yet been implicated in a human neurodevelopmental disorder.

View Article and Find Full Text PDF

Phenotype and imaging features associated with APP duplications.

Alzheimers Res Ther

May 2023

Department of Neurology and CNR-MAJ, Univ Rouen Normandie, U1245 and CHU Rouen, 76000, Rouen, France.

Background: APP duplication is a rare genetic cause of Alzheimer disease and cerebral amyloid angiopathy (CAA). We aimed to evaluate the phenotypes of APP duplications carriers.

Methods: Clinical, radiological, and neuropathological features of 43 APP duplication carriers from 24 French families were retrospectively analyzed, and MRI features and cerebrospinal fluid (CSF) biomarkers were compared to 40 APP-negative CAA controls.

View Article and Find Full Text PDF
Article Synopsis
  • Exome sequencing has a high diagnostic yield (25%-70%) for rare diseases, revealing novel gene associations, but retrospective data reanalysis can be challenging for labs.
  • The study employed a systematic reanalysis strategy utilizing daily PubMed searches and the GREP command-line tool to track new disease-gene associations over 18 months.
  • From their queries, they identified 128 genes of interest and confirmed causal diagnoses in 21 individuals, showcasing that this efficient reanalysis method can enhance diagnostic outcomes in genetic research.
View Article and Find Full Text PDF

CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury.

J Adv Res

January 2023

Normandy University, UniRouen, Inserm UMR1096 EnVI, FHU REMOD-VHF, F-76000 Rouen, France; Department of Pharmacology, Rouen University Hospital, F-76000 Rouen, France. Electronic address:

Introduction: Although the physiological role of the C-terminal hydrolase domain of the soluble epoxide hydrolase (sEH-H) is well investigated, the function of its N-terminal phosphatase activity (sEH-P) remains unknown.

Objectives: This study aimed to assess in vivo the physiological role of sEH-P.

Methods: CRISPR/Cas9 was used to generate a novel knock-in (KI) rat line lacking the sEH-P activity.

View Article and Find Full Text PDF
Article Synopsis
  • The blood-brain barrier is essential for protecting the central nervous system (CNS) and maintaining its balance, with Claudin-5 (CLDN5) being a key factor in its integrity.
  • Researchers discovered new mutations in the CLDN5 gene in 15 unrelated patients, who exhibited symptoms like developmental delays, seizures, and specific brain abnormalities.
  • By studying these variants in zebrafish, they found that these mutations likely disrupt the normal function of CLDN5, leading to a new neurodevelopmental disorder that affects both the blood-brain barrier and neuronal health.
View Article and Find Full Text PDF

Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort.

Eur J Med Genet

December 2022

Department of Human Genetics, Radboudumc Expert Center for PHTS, Radboud university medical center, Nijmegen, the Netherlands; Radboud university medical center, Radboud Institute for Health Sciences, Nijmegen, the Netherlands. Electronic address:

Article Synopsis
  • Pathogenic PTEN germline variants lead to PTEN Hamartoma Tumor Syndrome (PHTS), which exhibits a range of symptoms and genetic mutations, underscoring the importance of understanding these associations for better diagnostics and personalized treatment.
  • A study involving 510 patients identified 268 pathogenic variants, revealing trends such as adults having more truncating variants and children more often presenting with macrocephaly and developmental delays.
  • Findings suggest that the type of PTEN variant (missense vs. truncating) correlates with the age of disease onset and specific phenotypes, indicating that genetic variation influences the clinical features of PHTS.
View Article and Find Full Text PDF

Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome.

J Natl Cancer Inst

January 2023

Department of Human Genetics, Radboudumc Expert Center for PHTS, Radboud university medical center, Nijmegen, the Netherlands.

Background: PTEN Hamartoma Tumor Syndrome (PHTS) is a rare syndrome with a broad phenotypic spectrum, including increased risks of breast (BC, 67%-78% at age 60 years), endometrial (EC, 19%-28%), and thyroid cancer (TC, 6%-38%). Current risks are likely overestimated due to ascertainment bias. We aimed to provide more accurate and personalized cancer risks.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on "episignatures," which are unique DNA methylation patterns used as biomarkers for diagnosing various genetic syndromes, particularly neurodevelopmental disorders.
  • Researchers analyzed DNA methylation changes in 65 genetic syndromes, identifying specific differentially methylated probes (DMPs) and regions (DMRs) associated with these conditions.
  • Findings indicated that DMPs and DMRs were mostly located in gene promoters and pathways related to neurodevelopment, highlighting a connection between gene mutations and altered DNA methylation profiles in these disorders.
View Article and Find Full Text PDF

Oligodendrocyte lineage is severely affected in human alcohol-exposed foetuses.

Acta Neuropathol Commun

May 2022

Department of Pathology, Normandy Centre for Genomic and Personalized Medicine, Laboratoire d'Anatomie Pathologique, Pavillon Jacques Delarue, CHU, Normandie Univ, UNIROUEN, INSERM U1245 and Rouen University Hospital, 1 Rue de Germont, 76031, Rouen Cedex, France.

Prenatal alcohol exposure is a major cause of neurobehavioral disabilities. MRI studies in humans have shown that alcohol is associated with white matter microstructural anomalies but these studies focused on myelin abnormalities only after birth. Only one of these studies evaluated oligodendrocyte lineage, but only for a short period during human foetal life.

View Article and Find Full Text PDF

Unique or multiple congenital facial skin polyps are features of several rare syndromes, from the most well-known Pai syndrome (PS), to the less recognized oculoauriculofrontonasal syndrome (OAFNS), encephalocraniocutaneous lipomatosis (ECCL), or Sakoda complex (SC). We set up a research project aiming to identify the molecular bases of PS. We reviewed 27 individuals presenting with a syndromic frontonasal polyp and initially referred for PS.

View Article and Find Full Text PDF
Article Synopsis
  • The study addresses the challenge of manually reinterpreting sequenced genomic data due to human resource limitations and inconsistent procedures, highlighting the need for more efficient methods.* -
  • The Genome Alert! method automates the reporting of clinically significant changes in variant classifications from the ClinVar database, revealing a significant number of changes and new gene-disease associations over a two-year period.* -
  • The use of Genome Alert! resulted in a high validation rate of classification changes, leading to new diagnoses for several patients and the identification of valuable gene-disease associations not previously documented in existing databases.*
View Article and Find Full Text PDF

Detecting inversions in routine molecular diagnosis in MMR genes.

Fam Cancer

October 2022

Department of Genetics, Normandy Center for Genomic and Personalized Medicine, UNIROUEN, Inserm U1245 and Rouen University Hospital, CHU Rouen, Normandie University, 76000, Rouen, France.

Article Synopsis
  • Inversions, which are DNA orientation changes, can cause human diseases but are often overlooked because they do not produce an obvious imbalance in genetic material.* -
  • The study highlights two families: one with constitutional mismatch repair deficiency and history of colon cancer (F1), and another with a severe history of Lynch syndrome (F2), showcasing the impact of inversions on gene expression.* -
  • Utilizing a whole gene panel approach allowed for the detection of significant inversions in the PMS2 and MSH6 genes, emphasizing the importance of genomic sequencing in improving diagnosis rates.*
View Article and Find Full Text PDF

coding variants in the gene cause a neurodevelopmental disorder with intellectual disability.

J Med Genet

October 2022

Institut de génétique médicale d'Alsace (IGMA), Laboratoire de Diagnostic Génétique, Hôpitaux universitaires de Strasbourg, Strasbourg, Alsace, France.

Article Synopsis
  • This study investigates the role of high-impact genetic variants in over a thousand genes linked to Mendelian neurodevelopmental disorders (NDD) by characterizing 28 probands with de novo heterozygous coding variants.
  • Among the identified variants, 15 unique changes were found, including missense, in-frame deletions, and a splice variant, affecting the Argonaute 1 protein involved in gene-silencing pathways, which suggests these mutations may disrupt mRNA processing.
  • The affected individuals exhibited a range of symptoms, such as intellectual disabilities, speech and motor delays, and autistic behaviors, highlighting the potential significance of these genetic variants in understanding NDD.
View Article and Find Full Text PDF

The role of genetics in the development of osteoarthritis is well established but the molecular bases are not fully understood. Here, we describe a family carrying a germline mutation in () associated with three distinct phenotypes. The index case was enrolled for a familial form of idiopathic early-onset osteoarthritis.

View Article and Find Full Text PDF

Objective: Neurofilament light chain (NfL) is a promising biomarker in genetic frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). We evaluated plasma neurofilament light chain (pNfL) levels in controls, and their longitudinal trajectories in and cohorts from presymptomatic to clinical stages.

Methods: We analysed pNfL using Single Molecule Array (SiMoA) in 668 samples (352 baseline and 316 follow-up) of and patients, presymptomatic carriers (PS) and controls aged between 21 and 83.

View Article and Find Full Text PDF
Article Synopsis
  • DYRK1A syndrome is a common genetic cause of intellectual disability, and researchers aimed to better understand it and improve how to interpret challenging gene variants.
  • They analyzed clinical and molecular data from 50 individuals with DYRK1A variants and developed several useful tools, including a clinical score and methods to study the impact of these variants.
  • The study found that some variants thought to be harmful may not be, highlighting the need for caution in interpreting DYRK1A mutations, while the new tools will help in future assessments.
View Article and Find Full Text PDF

Neuropathological hallmarks of fetal hydrocephalus linked to CCDC88C pathogenic variants.

Acta Neuropathol Commun

June 2021

UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics and Reference Center for Developmental Disorders, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, 76000, Rouen, France.

The prevalence of congenital hydrocephalus has been estimated at 1.1 per 1000 infants when including cases diagnosed before 1 year of age after exclusion of neural tube defects. Classification criteria are based either on CSF dynamics, pathophysiological mechanisms or associated lesions.

View Article and Find Full Text PDF

Primary Progressive Aphasia Associated With Mutations: New Insights Into the Nonamyloid Logopenic Variant.

Neurology

July 2021

From Sorbonne Université (D.S., M.H., L.S., S.E., A.C., S.B., D.R., A.M., R.L., B.D., A.B., O.C., M.T., R.M., I.L.B.), Paris Brain Institute-Institut du Cerveau (ICM), Inserm U1127, CNRS UMR 7225, AP-HP-Hôpital Pitié-Salpêtrière; Reference Centre for Rare or Early Dementias (D.S., S.F., M.N.-L., M.H., A.F., L.S., S.E., D.R., A.M., R.L., B.D., M.T., R.M., I.L.B.), IM2A, Département de Neurologie, AP-HP-Hôpital Pitié-Salpêtrière; Aramis Project Team (D.S., S.E., S.B., A.M., O.C.), Inria Research Center of Paris; Centre of Excellence of Neurodegenerative Disease (CoEN) (M.H.), ICM, CIC Neurosciences, Département de Neurologie, AP-HP-Hôpital Pitié-Salpêtrière, Sorbonne Université; FrontLab (A.F., R.L., B.D., M.T., R.M., I.L.B.), Paris Brain Institute-Institut du Cerveau (ICM); Université Lille (V.D., F.P.), Inserm U1171, CHU Lille, DistAlz, LiCEND, CNR-MAJ; CMRR Service de Neurologie (P.C.), CHU de Limoges; Department of Neurology (J.P., A.G.), Toulouse University Hospital; ToNIC (J.P., A.G.), Toulouse NeuroImaging Centre, Inserm, UPS, University of Toulouse; Normandie Université (D.W., D.H.), UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Neurology and CNR-MAJ, Normandy Center for Genomic and Personalized Medicine; Rouen University Hospital (O.M.), Department of Neurology; Normandie Université (O.M.), UNICAEN, PSL Research University, EPHE, INSERM, U1077, CHU de Caen Normandie, Neuropsychologie et Imagerie de la Mémoire Humaine, Caen; UF de Neurogénétique Moléculaire et Cellulaire (F.C.), Département de Génétique, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix; EPHE (A.C.), PSL Research University, Paris; CMRR Nouvelle Aquitaine/Institut des Maladies Neurodégénératives clinique (IMNc) (S.A.), CHU de Bordeaux Hôpital Pellegrin; Unit of Neurology of Memory and Language (M.S., J.L., C.R.-J.), GHU Paris Psychiatry and Neurosciences, University of Paris, Hôpital Sainte Anne; Université Paris-Saclay (M.S., J.L., C.R.-J.), CEA, CNRS, Inserm, BioMaps, Orsay; Aix Marseille Université (M.D.), INSERM, Institut de Neurosciences des Systèmes, Marseille; APHM (M.D.), Timone, Service de Neurologie et Neuropsychologie, APHM Hôpital Timone Adultes, Marseille; CHU Nantes (C.B.-B.), Inserm CIC04, Department of Neurology, Centre Mémoire de Ressources et Recherche, Nantes; Centre de génétique (C.T.-R.), Hôpital d'Enfants, CHU Dijon Bourgogne; CMRR Département de Neurologie (F.S.), Hôpitaux Civils, Colmar, INSERM U1118, Université de Strasbourg, Faculté de Médecine, 67085 Strasbourg; CMRR (A.G.), Département de Neurologie, CHU de Montpellier, Inserm U1061, Université de Montpellier i-site MUSE; Department of Neurology (F.E.-B.), CMRR Angers University Hospital, Angers, France; Department of Advanced Medical and Surgical Sciences (C.C.), University of Campania Luigi Vanvitelli, Naples, Italy; and Department of Neurology (M.L.G.-T.), Memory and Aging Center, University of California, San Francisco.

Objective: To determine relative frequencies and linguistic profiles of primary progressive aphasia (PPA) variants associated with (progranulin) mutations and to study their neuroanatomic correlates.

Methods: Patients with PPA carrying mutations (PPA-) were selected among a national prospective research cohort of 1,696 patients with frontotemporal dementia, including 235 patients with PPA. All patients with amyloid-positive CSF biomarkers were excluded.

View Article and Find Full Text PDF

When a maternal heterozygous mutation of the CYP24A1 gene leads to infantile hypercalcemia through a maternal uniparental disomy of chromosome 20.

Mol Cytogenet

May 2021

Normandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics and Reference Center for Developmental Disorders, Normandy Center for Genomic and Personalized Medicine, 76000, Rouen, France.

Background: Infantile hypercalcemia is an autosomal recessive disorder caused either by mutations in the CYP24A1 gene (20q13.2) or in the SLC34A1 gene (5q35.3).

View Article and Find Full Text PDF